Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.3527
-0.0173 (-4.68%)
Jul 10, 2026, 4:00 PM EDT - Market closed
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $7.55 million as of July 10, 2026. Its market cap has decreased by -28.97% in one year.
Market Cap
7.55M
Enterprise Value
3.88M
1-Year Change
-28.97%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $7.55M, a decrease of -77.38%. That is a compound annual growth rate of -55.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 7.55M | -48.92% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imunon | 8.49M |
| TransCode Therapeutics | 8.39M |
| Cadrenal Therapeutics | 8.29M |
| Jupiter Neurosciences | 8.25M |
| Aspire Biopharma Holdings | 7.78M |
| CNS Pharmaceuticals | 7.55M |
| PharmaCyte Biotech | 7.48M |
| Bolt Biotherapeutics | 7.26M |